Aktis Oncology, Inc.
AKTS
$24.07
▲
+0.58
(+2.47%)
at close
0
Visible periods
0
Metrics
Peer-ranked
Benchmarks
Price Chart
insights
Verdict pending
Sync financial data to generate a health grade for this company.
auto_awesome
Analytical Summary
Review the statement evidence below to form a view on AKTS.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
—
FCF / Share
—
Trailing P/E
—
Price / Book
—
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Aug 7, 2026.
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Financial data not yet available
AKTS is in our catalog but has no SEC-derived metrics ingested yet. Sign in to pull the latest SEC filing for this ticker.
Nothing to visualize yet
Financial data hasn't been synced for this company.
Secondary lens
Benchmark Lens
Compare AKTS against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare AKTS against peers after checking the statement evidence.
Compare AKTS with peers
Stack AKTS against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago